Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

PCI given the green light in ANVISA audit

Leading packaging services provider expects approval from National Health Surveillance Agency of Brazil for secondary packaging

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Commercial packaging and clinical trial services specialist Packaging Coordinators, Inc. (PCI) has today announced that its UK facility had a positive inspection and expects to achieve approval from the National Health Surveillance Agency of Brazil (ANVISA) to carry out secondary packaging for the importation of a pharmaceutical product into Brazil.

The continued growth of the global pharmaceutical market brings with it a number of complexities. Each country has its own jurisdiction with regards to the importation of pharmaceutical goods, which companies must meet to allow access to that market. As such, it is imperative that any third party contractor also meets the required standards and is accredited to continue supply.

Working directly in line with a specific customer request, to package a product that was to be used in Brazil, PCI have been working closely with the customer to prepare the Hay on Wye site for audit. The ANVISA audit was successfully executed and there were no findings or adverse comments and the inspectors were happy to recommend the site be certified for secondary packaging. The inspectors also credited the site for a number of strong processes including their controls for segregation, control of the product in the warehouse and production as well as the control of temperature, validation, and Preventative Maintenance.

PCI’s European based site joins PCI’s North American sites in Philadelphia, PA and Rockford, IL as having successful regulatory audits by ANVISA for product destined for the Brazilian market.

“We are extremely proud to have had such a positive audit from ANVISA” stated Kay O’Hagan, Quality Assurance and Regulatory Affairs Director. “A successful audit and subsequent approval demonstrates that PCI works hard to meet stringent regulatory standards and provides continued confidence to our clients.”

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging